Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress

Go back to Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress

Autolus Therapeutics (AUTL) Tops Q1 EPS by 4c

May 4, 2023 7:28 AM EDT

Autolus Therapeutics (NASDAQ: AUTL) reported Q1 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

... More